These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30589671)

  • 21. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.
    Nicolau C; Sala E; Kumar A; Goldman DA; Schoder H; Hricak H; Vargas HA
    AJR Am J Roentgenol; 2017 Apr; 208(4):849-853. PubMed ID: 28095016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake.
    Xia X; Hu F; Qin C; Liu F; Lan X
    Clin Nucl Med; 2019 Jan; 44(1):38-39. PubMed ID: 30371589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unusual case of retroperitoneal synovial sarcoma with CT, MRI, and F-18 FDG PET/CT findings.
    Tabar M; Gultekin MA; Peker AA; Toprak H
    J Clin Ultrasound; 2024 Jan; 52(1):89-91. PubMed ID: 37947310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function.
    Jadoul A; Lovinfosse P; Weekers L; Delanaye P; Krzesinski JM; Hustinx R; Jouret F
    Clin Nucl Med; 2016 Sep; 41(9):683-7. PubMed ID: 27405040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
    Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
    Wang Y; Dong A; Yang B; Lu J
    Clin Nucl Med; 2018 May; 43(5):e160-e163. PubMed ID: 29432340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Pulmonary Artery Sarcoma on Dual-Time Point FDG PET/CT Imaging.
    Li J; Zhao Q; He L; Zhuang X; Li F
    Clin Nucl Med; 2016 Aug; 41(8):656-8. PubMed ID: 27163460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethmoidal and extranodal Burkitt lymphoma in a child with bilateral kidney Burkitt lymphoma lesions incidentally detected by
    Bonacina M; Bertoli M; Albano D; Bertagna F; Laffranchi F; Giubbini R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):384-386. PubMed ID: 29636232
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors.
    Gündoğan C; Çermik TF; Erkan E; Yardimci AH; Behzatoğlu K; Tatar G; Okçu O; Toktaş MG
    Nucl Med Commun; 2018 Dec; 39(12):1174-1182. PubMed ID: 30234688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
    Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
    J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
    Wang P; Hou G; Li F; Cheng X
    Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
    Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
    Thambugala GM; Mohamed A; O' Neill GF; Fulham MJ
    Australas Radiol; 2006 Dec; 50(6):604-6. PubMed ID: 17107535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of incidental intra-articular and peri-articular FDG avid foci on PET/CT.
    Cohen-Levy WB; Pretell-Mazzini J; Singer AD; Subhawong T; Greif DN; Jose J
    Acta Radiol; 2019 Jan; 60(1):78-84. PubMed ID: 29665710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18 F-FDG PET/CT in a Case of Clear Cell Sarcoma of the Kidney.
    Jin H; Yin Y; Wang H; Cheng W
    Clin Nucl Med; 2024 May; 49(5):468-469. PubMed ID: 38377388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG PET/CT differentiating two malignant tumors in the same patient.
    Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
    Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
    Ge J; Zuo C; Guan Y; Liang Z
    Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.
    Nakaigawa N; Kondo K; Ueno D; Namura K; Makiyama K; Kobayashi K; Shioi K; Ikeda I; Kishida T; Kaneta T; Minamimoto R; Tateishi U; Inoue T; Yao M
    BMC Cancer; 2017 Jan; 17(1):39. PubMed ID: 28068944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET/CT Findings of Renal Cell Carcinoma Arising From a Transplanted Kidney in a Pediatric Patient.
    Fleury AS; Zhuang H
    Clin Nucl Med; 2023 Dec; 48(12):e605-e607. PubMed ID: 37844572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.